BIA
LEGN icon

Bell Investment Advisors’s Legend Biotech LEGN Stock Holding History

Bell Investment Advisors’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$405 Buy
+14
New +$378 ﹤0.01% 1772
2025
Q4 		– Sell
-48
Closed -$1.57K – 1878
2025
Q3 		$1.57K Hold
48
– – ﹤0.01% 1415
2025
Q2 		$1.7K Sell
48
-68
-59% -$2.2K ﹤0.01% 1409
2025
Q1 		$3.94K Buy
116
+61
+111% +$2.19K ﹤0.01% 1023
2024
Q4 		$1.79K Sell
55
-80
-59% -$3.31K ﹤0.01% 1382
2024
Q3 		$6.58K Sell
135
-7
-5% -$373 ﹤0.01% 792
2024
Q2 		$6.29K Buy
142
+15
+12% +$692 ﹤0.01% 818
2024
Q1 		$7.12K Buy
127
+7
+6% +$422 ﹤0.01% 728
2023
Q4 		$7.22K Buy
120
+1
+0.8% +$63 ﹤0.01% 696
2023
Q3 		$7.99K Sell
119
-9
-7% -$625 ﹤0.01% 590
2023
Q2 		$8.84K Sell
128
-20
-14% -$1.31K ﹤0.01% 558
2023
Q1 		$7.14K Sell
148
-67
-31% -$3.28K ﹤0.01% 613
2022
Q4 		$10.7K Buy
215
+69
+47% +$3.34K ﹤0.01% 466
2022
Q3 		$6K Sell
146
-112
-43% -$5.26K ﹤0.01% 598
2022
Q2 		$14K Buy
+258
New +$10.9K ﹤0.01% 346
2021
Q4 		$5K Sell
101
-94
-48% -$4.77K ﹤0.01% 771
2021
Q3 		$10K Buy
+195
New +$8.11K ﹤0.01% 458

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Bell Investment Advisors's LEGN Position: Q2 2026 in Review

Bell Investment Advisors opened a new position in Legend Biotech (LEGN) in Q2 2026: 14 shares worth $405. The stake represents ﹤0.01% of the portfolio and ranks #1772 among its holdings. This is a return to the name: Bell Investment Advisors previously reported a position in LEGN as recently as Q3 2025.

Bell Investment Advisors first reported a position in LEGN in Q3 2021 and has held it in 17 quarters since. The position peaked at $14K in Q2 2022. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Bell Investment Advisors held 14 shares of Legend Biotech worth $405 as of Q2 2026.
  • Legend Biotech was a new Bell Investment Advisors position in Q2 2026.
  • Legend Biotech made up ﹤0.01% of Bell Investment Advisors's portfolio in Q2 2026, its #1772 holding.
  • Bell Investment Advisors first reported a position in Legend Biotech in Q3 2021 and has held it in 17 quarters since.
  • Bell Investment Advisors's Legend Biotech position peaked at $14K in Q2 2022.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.